Aug 13, 2024
1:5
For every 5 shares held, investors received 1. The price per share adjusted from $0.48 to $0.10.
The split itself did not change the total investment value.
Monopar Therapeutics Inc. (MNPR) trades on the NASDAQ in the Biotechnology industry.
Monopar Therapeutics Inc. company overviewThe latest split shown was on August 13, 2024. It was a 1-for-5 reverse split, so shareholders received 1 share for every 5 they held.
This history records one reverse split, on August 13, 2024.